Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Clearly JB doesn't want the share price to go too yet just yet as he is accumulating ridiculous number of options at a very low price. Once he has about 10-15million he will probably start producing more positive news feeds. Never met a board that aren't kmly jn.it for themselves!
I have previously questioned whether the BoD had a cunning plan, for not being proactive in reacting to positive news. I have now concluded that the BoD are in infect, acutely inapt.
They appear to be happy to doddle along drawing on their current remuneration.
That it takes a PI to share the latest positive news and stop the share price slide.
SHAME on you JB.
If only there was a mechanism to remove him.He has always been way out of his depth.
Don’t get me started on the CFO.
All credit for Finnish news must go to milktrayman, I only copied and pasted it to Investor relations
Indeed nice one Busters, the BOD needs their heads knocking together. I wasn't aware of the launch in Norway and to then be a top seller in only two weeks surely this is newsworthy?
I think the tree shake will now see a very poweful rally
Nice one busters, salute you sir. Pls keep us updated with how it goes, I too will be looking forward to their response.
Although the CEO stated the company has no control over the share price, it can issue news items which helps sentiment and supports the share price.
Why doesn't the company issue Reach RNS's when positive news is announced by its distributors such as the recent one for Norway......
“The successful launch in Norway of Eroxon® in February was an important and significant event. After only two weeks in the market, this clinically proven local treatment of erectile dysfunction was the bestseller at an online pharmacy. Strong sales in the rest of the first quarter, resulted in Eroxon® ranking third on Navamedic’s most sold products in the Consumer Health segment. Eroxon® will be launched in Sweden in May, and in Finland later this year,” said Kathrine Gamborg, CEO of Navamedic ASA.
https://news.cision.com/navamedic-asa/r/navamedic-q1-2024--successful-product-launch-and-steady-operational-progress,c3970410
Snippets of news like this would go a long way to underpin the share price rather than allow the constant drip, drip downwards. Private investors cannot allow their savings to reduce day after day so consequently have to limit their losses by selling where as Institutional investors hold for the long term. What is the company doing to attract more Institutional investors ?
Hoping you will pass this on to the board, I look forward to hearing their response
Sent to Investor relations today.
FYI :
“The successful launch in Norway of Eroxon® in February was an important and significant event. After only two weeks in the market, this clinically proven local treatment of erectile dysfunction was the bestseller at an online pharmacy. Strong sales in the rest of the first quarter, resulted in Eroxon® ranking third on Navamedic’s most sold products in the Consumer Health segment. Eroxon® will be launched in Sweden in May, and in Finland later this year,” said Kathrine Gamborg, CEO of Navamedic ASA.
https://news.cision.com/navamedic-asa/r/navamedic-q1-2024--successful-product-launch-and-steady-operational-progress,c3970410
I personally can’t see the point in the company anymore as it only exists for Eroxon! Haleon are doing everything their end from manufacture to distribution, coopers only distribution with 3rd party manufacture. Once the outstanding deals are completed then the BoD are redundant in my eyes, not much to develop & expand the range with really.
Bandit
I am not saying the management team is top notch, nor that it is appropriate for them to get all these options.
BUT, if your thesis is correct, and they have struck dreadful deals, what good is it to have them at a strike price of 35.5?
I put it to you that they don’t think the share price is likely to stay where it is long term. Maybe they are wrong because they are so incompetent they don’t even realise.
Or maybe the deals aren’t as bad as you assume?
Surfie 1961 - your logic is flawed. If you fear for the value of your investment - SELL. if you still have investment faith in an uplift of the share price from hereon in - BUY - if only to reduce your average price to give you a better chance of breaking even. All the good guides on investing advocate this approach. Neither approach guarantees success of course but at least there is some risk mitigation. The risk of "losing" more of your FUM investment, or clawing back some of your, as yet "unrealised loss".
For the record I am long and strong. Average purchase price just under 40p from averaging down.
The new website now only mentions Eroxon & sexual health, no mention of the technology Dermasys! So they have clearly thrown all their eggs into one basket! Clearly have been advised to do this & hopefully for a sale of the company at some point in the near future. Although I’m frustrated with the SP & the BoD, I do think we will see decent returns soon as do LO/ADAMS & the other major investors who are holding strong!
That £1.50 target is a bloody joke. I have been in and out of FUM for well over 10 years and NEVER made a penny. I can't remember this even getting past 60p and that was because we got the go ahead to sell in the States. Many long term holders flagged this milestone as the beginning of great things and we are now down nearly 50% since then yet the BOD sees fit to reward themselves further. If I wasn't down so much I would get out of here for good.
I wondered how long it would take for some to realise that we have a very weak CEO/CFO in this company. The R&D success was down to Ken James and the real weakness is that we don’ t have the brainpower at operating executive level to make the most of this opportunity. I have been beating this drum for longer than I care to remember so having sold out fully after 7 years I will continue to watch from the sidelines in the hope that our relatively new Chairman has had long enough in situ to figure this out for himself and bring in some quality people. Sadly, it may be too late as the key commercial deals have already been done! Another small business that promises much yet fails to deliver whilst the average managers make sure they are rewarded generously. Main Directors, hopefully, will be up for re-election at the AGM so that is the time to express your dissatisfaction with their performance.
Oh dear. I had no idea that they were not medics I have been building up my holding at these low prices. Time to take a break? I do hope I’ll regret not buying more at these price - especially when a £1.50 target was flagged up recently.
The BoD have been milking the cow for the last 20 years, and will continue to do so, as well as taking a bloody good salary to go with that! They have given up on all other products yet say they are good at R&D, well if that was the case why didn’t they get other products to market successful! And let’s be honest they stumbled onto Eroxon by accident in the end! Let’s face it JB is an insurance broker by trade and AH sells alcoholic drinks at wedding venues from a mobile pub? Not really the credentials we want running FUM! Surely time for LB to take a majority stake & dump these two clowns not reward them. RNS states when milestones are met what are they??
Well it means they have a big financial incentive to take actions that drive the share price higher.
The question is, have they already taken those actions? And we are waiting for events to play out?
Any RNS or no RNS seems to cause the share price to drop. The only chink of light is the recent award of share options makes me think that some folk at the top ( who received these options ) must feel it will come good. Hope I live long enough to share that joy.
"share options" and they're only really worth anything if the SP goes up.
Lol
This looks new?
https://www.tipranks.com/news/company-announcements/futura-medical-grants-share-options-to-leaders
That and the fact that people expected more newsflow, near the end of April and still no US launch RNS which will be a marker for the re rate. Haleon could still pull the plug on this, once that's notified to the market that deal becomes real.
Somebody is still dumping large amounts of stock, no idea why, maybe nothing to do with FUM.
Until they clear, we won't re rate.